Related by context. All words. (Click for frequent words.) 82 Genasense R 81 Ganite ® 81 Genasense ® 80 Ganite 67 Campath ® 67 Raptiva ® 67 REPLAGAL 67 label Lipofen R 66 Raptiva R 65 Onco TCS 65 Wafer polifeprosan 65 YONDELIS 65 ™ pralatrexate injection 65 INTEGRILIN 64 Clolar ® 64 phase III isavuconazole 64 branded Rectogesic 64 BYETTA ® 64 Amrubicin 64 LEUKINE 64 methylnaltrexone bromide 64 highly purified pasteurized 64 Besivance 63 Virulizin R 63 IMiDs ® compound 63 Fibrillex TM 63 Nimotuzumab 63 FOLOTYN ® 63 unique alkylating agent 63 Dacogen injection 63 BioNumerik 63 Vicinium TM 63 R sorafenib tablets 63 Genasense 63 oral ridaforolimus 63 Belimumab 63 product BioThrax ® 63 RANK Ligand inhibitor 63 thymosin alpha 1 63 Tibotec Therapeutics division 63 markets HP Acthar 63 VPRIV 63 Gemzar ® 63 docetaxel Taxotere ® 63 Orphan Drug designations 63 JOULFERON 63 R bendamustine hydrochloride 63 Ixempra 63 EOquin TM 62 oropharyngeal candidiasis 62 equine osteoarthritis marketed 62 FUSILEV ® 62 AzaSite Xtra 62 Fludara ® 62 EGFR expressing mCRC 62 Intravenous Human 62 dasatinib Sprycel ® 62 Taiho Pharmaceutical 62 HYVISC ® treatment 62 COMFORT II 62 ABILIFY ® 62 TRACON Pharmaceuticals Inc. 62 Aurexis 62 Cellegesic 62 ZALBIN 62 TEMODAL 62 Urocidin TM 62 Kristalose ® lactulose 62 Certican 62 Modrenal R 62 EGFR expressing metastatic colorectal 62 apaziquone 62 TYZEKA 62 Treatment IND 62 Aloxi R 62 EGRIFTA TM 62 PDX pralatrexate 62 Oracea ® 62 VIVITROL ® 62 Plenaxis R 62 acyclovir Lauriad R 62 Thrombin topical Recombinant 62 adult chronic ITP 61 intravesical infusion therapy 61 Preotact 61 sorafenib tablets 61 IRESSA 61 VANTAS 61 terlipressin 61 phase IIb clinical 61 Civacir 61 GTC recombinant form 61 Zorbtive TM 61 Phase #b/#a clinical 61 RhuDex ® 61 cutaneous T 61 SUPPRELIN R LA 61 SYCREST 61 Pirfenidone 61 erlotinib Tarceva ® 61 THALOMID 61 CoreValve System 61 GLASSIA 61 AA amyloidosis 61 Talabostat 61 leading oral taxane 61 IL# PE#QQR 61 Ridaforolimus 61 anticancer compound 61 Xeloda ® 61 Increlex R 61 GATTEX TM 61 Cloretazine ® 61 Amitiza 61 ZADAXIN ® 61 DepoBupivacaine TM 61 huC# DM4 61 severe hypercholesterolemia 61 liver resection surgeries 61 FOLOTYN 61 opioid induced constipation OIC 61 REBETOL combination therapy 61 BAY #-# 61 IV Busulfex 61 Aryplase 61 forodesine 61 personalized cellular immunotherapy 61 Nexavar ® 61 Ceflatonin ® 61 Combidex 61 ELAPRASE 61 Lucanix R 61 Angiox R 61 targeted radiotherapeutic 61 MEZAVANT 61 RAPTIVA 61 ProEthic Pharmaceuticals 61 cinacalcet HCl 61 prGCD 61 OLEPTRO TM 61 COLAZAL R 61 advanced metastatic prostate 61 IMiDs 61 TORISEL 60 UPLYSO 60 FRDA 60 BiovaxID TM 60 Dapagliflozin 60 Tamibarotene 60 Argatroban 60 Onalta TM 60 TRISENOX ® 60 Phase Ib IIa 60 SinuNase TM 60 Somatuline Depot 60 ABILIFY R 60 TRANSDUR ® 60 Allovectin 7 ® 60 Neulasta R 60 XAGRID 60 HCV protease inhibitor 60 relapsed multiple myeloma 60 HepaGam B 60 IgG1 monoclonal antibody 60 DOXIL R 60 Preotact R 60 Panzem R 60 Vitrasert R 60 Methylnaltrexone 60 pseudobulbar affect PBA 60 Kuvan R 60 Granted Orphan Drug 60 Eprodisate KIACTA TM 60 delivers fluocinolone acetonide FA 60 ATryn R 60 Tramiprosate ALZHEMED TM 60 Naglazyme 60 Ceflatonin R 60 Romiplostim 60 OMP designation 60 FUZEON ® 60 TRANSDUR ™ 60 GTC recombinant human 60 BCG refractory carcinoma 60 EDEMA3 60 ONSOLIS 60 Zenpep 60 Oracea TM 60 ezogabine 60 receptor tyrosine kinase inhibitor 60 topical NSAID 60 STRIANT R 60 refractory multiple myeloma 60 herpetic keratitis 60 albinterferon alfa 2b 60 Pegloticase 60 naproxen esomeprazole magnesium 60 ThermoDox R 60 Movectro 60 TRISENOX 60 Kit CD# positive 60 relapsed refractory multiple myeloma 60 silodosin 60 Lubiprostone 60 dirucotide MBP# 60 ONCASPAR 60 Eloxatin ® 60 ALVESCO R 60 investigational pharmacologically unique 60 Sebivo 60 relapsed leukemia 60 octreotide implant 60 OvaRex ® MAb 60 ADVEXIN p# therapy 60 ZEFTERA TM Zevtera TM 60 R rilonacept Injection 60 PEG INTRON 60 bile duct tumor 60 R lenalidomide 60 GW# [003] 60 Pivotal Phase III 60 Fortigel 60 Fabry Disease 60 Rectogesic 60 IMiDs R 60 arsenic trioxide injection 60 BUPHENYL R 60 Iluvien ® 60 mertansine 60 Nexavar sorafenib 60 Receives Fast Track 60 Marketing Authorization Application MAA 60 nasal calcitonin product 60 docetaxel Taxotere R 60 PrevOnco 60 DepoDur 60 STRIANT ® 60 Indaflex TM 60 Bendamustine 60 Plicera 60 AEG# 59 NYSE Amex PTN 59 oncolytic virus therapies 59 Dacetuzumab 59 IV APAP 59 novel oral anticoagulant 59 Angiox 59 methylnaltrexone 59 Onalta 59 Liprotamase 59 Initiates Enrollment 59 Tavocept 59 VISICOL R 59 Loramyc 59 Onalta ™ 59 MOVIPREP R 59 Xyrem ® 59 Nabi HB Intravenous 59 eprodisate KIACTA TM 59 Aflibercept 59 Orphan Drug status 59 rasagiline tablets 59 PEGylated anti 59 hepatitis C HCV 59 Dementia Related Psychosis 59 Mimpara 59 refractory chronic lymphocytic 59 Clevudine 59 XIAFLEX ™ 59 Nitoman 59 topically applied SEPA 59 Soliris TM eculizumab 59 NUEDEXTA ™ 59 EGFr expressing metastatic colorectal 59 metastatic hormone refractory 59 Tarceva TM 59 pediatric glioma 59 relapsing remitting MS RRMS 59 thetreatment 59 Alemtuzumab 59 BLP# Liposome Vaccine 59 Zirgan 59 HepeX B TM 59 PROMACTA 59 hepatitis B HBV 59 Crofelemer budesonide foam 59 rilonacept 59 Zolinza 59 KNS # 59 Nipent R 59 ThermoDox ® 59 chronic ITP patients 59 #D#C# 59 vitreoretinal disorders 59 Orapred ODT 59 Degarelix 59 AMITIZA R 59 MAGE A3 ASCI 59 myelodysplastic myeloproliferative diseases 59 Mepact 59 Sanvar R 59 Tostrex 59 Diabetic Macular Edema 59 HYVISC R 59 ferumoxytol Injection 59 Abbokinase 59 Ecallantide 59 REVLIMID lenalidomide 59 proteasome inhibitor 59 Gentamicin Surgical Implant 59 POSIDUR 59 DORIBAX 59 ELADUR ™ 59 Veronate 59 XL# anticancer compounds 59 Taxotere docetaxel 59 Teysuno 59 castrate resistant prostate cancer 59 Troxatyl 59 aerosolized AAT 59 cutaneous T cell 59 Pivotal Trial 59 Eraxis 59 Kepivance 59 Jevtana 59 MOZOBIL 59 ZEFTERA TM 59 Albugon 59 registrational 59 LymphoStat B TM 59 Octreolin 59 commercialize AzaSite 59 AMITIZA lubiprostone 59 Marketing Authorization Application 59 vinorelbine tartrate 59 orphan medicinal product 59 PHX# 59 Marketing Authorisation Application 59 FASLODEX 59 SUMAVEL 59 INEGY 59 AVASTIN 59 candidate epratuzumab 59 ELADUR TM 59 Personalized Immunotherapy 59 Simulect 59 Application MAA 59 Hepatocellular Carcinoma HCC 59 Silodosin 59 equine osteoarthritis 59 ATryn ® 59 Specifid 59 TNF Tumor Necrosis Factor 59 Taliglucerase alfa 58 Investigational Device Exemption 58 Advanced Renal Cell 58 Solasia 58 Clinical Trials Agreement 58 SUCCEED trial 58 EOquin 58 refractory cutaneous T 58 PEGINTRON TM 58 Bukwang Pharmaceuticals 58 lexidronam injection 58 sunitinib malate 58 Retacrit 58 recurrent glioblastoma multiforme 58 PGL# 58 Levoleucovorin 58 Tanespimycin 58 AzaSite Plus 58 Anturol TM 58 NOXAFIL 58 Navelbine ® 58 RELISTOR ® 58 Tocilizumab 58 Phase III Clinical Trial 58 RECOTHROM R 58 REVLIMID R 58 BR.# 58 Rebif ® 58 ARCALYST R 58 SUPPRELIN LA 58 TREANDA 58 oral iron chelator 58 QUADRAMET R 58 Medtronic CoreValve System 58 Luveniq 58 trastuzumab DM1 T DM1 58 Bezielle 58 BRILINTA 58 Nebido 58 Allovectin 7 58 TELCYTA 58 IXIARO 58 Oravig ® 58 Solzira TM 58 MERREM 58 reslizumab 58 anti inflammatory NSAID 58 Xolegel 58 Yondelis ® 58 pitavastatin 58 DexaSite 58 XIAFLEX ® 58 INSPIRE Trial Phase III 58 interferon gamma 1b 58 Frova R 58 sapropterin dihydrochloride Tablets 58 Orphan Drug designation 58 rALLy clinical trial 58 alvimopan 58 Somatuline R Autogel R 58 Traficet EN 58 mitogen activated ERK kinase 58 Sapacitabine 58 Hedgehog Pathway Inhibitor 58 PROSTASCINT R 58 refractory Hodgkin lymphoma 58 Albuferon TM 58 Rituxan rituximab 58 commercializing Loramyc ® 58 Zenvia ™ 58 ADP receptor antagonist 58 Chronic Idiopathic Constipation 58 Æterna Zentaris 58 TRISENOX R 58 Belinostat 58 romiplostim 58 registrational trial 58 Loramyc ® 58 including eniluracil ADH 58 Gamunex C 58 Augment Injectable 58 GATTEX ® 58 Drug Eluting Stent System 58 intravenous formulations 58 HuCAL PLATINUM ® CysDisplay 58 Orphan Drug Status 58 HuMax TAC 58 Fibrin Pad 58 Phase IIIb clinical 58 clofarabine 58 oxandrolone USP 58 taliglucerase alfa 58 Sensipar R 58 placebo controlled Phase III 58 BLA submission 58 Proellex TM 58 GEM OS2 58 Orphan Medicinal Product 58 BENLYSTA ® 58 NEUPOGEN 58 Peginterferon alfa 2b 58 Lambert Eaton Myasthenic 58 Enzyme Replacement Therapy 58 Daclizumab 58 Brilique 58 INVANZ 58 IMiDs ® 58 CryoSeal FS System 58 Zytiga 58 trastuzumab Herceptin R 58 Retisert ® 58 FDA Orphan Drug 58 JAK inhibitor 58 ridaforolimus 58 Fortical R 58 Phase IIa clinical trials 58 oral calcitonin 58 tizanidine hydrochloride short 58 severe gastroparesis 58 Icatibant 58 Tetrabenazine 58 oncology indications 58 RELOVAIR ™ 58 sapropterin dihydrochloride 58 arthritis PsA 58 CRMD# 58 Zegerid OTC 58 Phase Ib II 58 Velcade bortezomib 58 STELARA TM 58 Junovan 58 AMMONUL R 58 paclitaxel Taxol ® 58 Mipomersen 58 MAA submission 58 velaglucerase alfa 58 GAMMAGARD 58 HER2 positive metastatic breast 58 PROVIGIL ® 58 dihydrochloride Tablets 58 Frova ® 58 MKC# MT 58 PI3K/Akt pathway inhibitor 58 PROVIGIL R 57 Cx# [002] 57 Bafetinib 57 regadenoson 57 TheraCIM 57 Tarsa Therapeutics 57 recurrent NSCLC 57 ONSOLIS TM 57 AMEVIVE 57 induced macular edema 57 Proquin XR 57 Syndrome LEMS 57 dextromethorphan quinidine 57 atypical antipsychotic medication 57 hyaluronidase enzyme 57 epoprostenol sodium 57 JV SpeBio 57 Actemra 57 lintuzumab SGN 57 Evoltra 57 palonosetron hydrochloride injection 57 Testim R 57 TELINTRA 57 ONTAK 57 developing Bicifadine serotonin 57 ZOSTAVAX 57 Firdapse TM amifampridine phosphate 57 Hycamtin 57 SPL# Gel vaginal microbicide 57 ZOLINZA 57 lucinactant 57 Ciclesonide 57 Pegintron 57 bendamustine HCl 57 refractory peripheral T 57 Diovan Exforge Tekturna Zelnorm 57 NeoVisc R 57 phase IIb trial 57 GABITRIL 57 Voreloxin 57 dirucotide 57 testosterone buccal system 57 Telavancin 57 5 HT3 antagonist 57 CIMZIA r 57 erlotinib Tarceva R 57 Panzem R NCD 57 rilonacept Injection 57 Arzerra ofatumumab 57 metastatic neuroendocrine tumors 57 levocetirizine 57 Elagolix 57 OMNARIS HFA 57 Combination REOLYSIN R 57 Insegia 57 Thalomid ® 57 ZACTIMA 57 Medidur TM FA 57 Phase III Pivotal 57 humanized monoclonal antibody 57 Gleevec Glivec 57 TYGACIL 57 RAPTIVA r 57 investigational immunotherapy 57 ONGLYZA ™ 57 Glufosfamide 57 candidates Azedra TM 57 Pivotal Clinical Trial 57 Nasdaq PGNX today 57 Virulizin ® 57 zileuton tablets 57 ospemifene 57 LHRH antagonist 57 oxymorphone ER 57 NEBIDO R 57 ularitide 57 Adenuric R 57 Receives Orphan Drug 57 MyVax R 57 HuMax CD4 57 SEBIVO 57 promote ceftobiprole 57 TM pralatrexate injection 57 * olmesartan medoxomil 57 NOTE POSIDUR ™ 57 Cetrorelix 57 evaluating picoplatin 57 OMAPRO ™ 57 Friedreich Ataxia FRDA 57 Zemiva TM 57 Abiraterone acetate 57 refractory metastatic colorectal cancer 57 FAME Study 57 Completes Patient Enrollment 57 Copegus R 57 MKC# MKC# PP 57 Actemra tocilizumab 57 autologous cellular immunotherapy 57 Lovaza TM 57 Allovectin 7 R 57 Ofatumumab 57 Genasense ® oblimersen 57 Fast Track Status 57 LUNESTA ® 57 zanolimumab 57 Solazed TM 57 formerly LymphoStat B 57 pralatrexate 57 monoclonal antibody IgG1 Mab 57 topical gel formulation 57 PERLANE 57 Cutaneous T 57 small molecule Hedgehog 57 candidate XP# 57 lenalidomide Revlimid R 57 ® tiagabine hydrochloride 57 subcutaneous formulation 57 Phase III Trial 57 EFJohnson 3e Technologies 57 SANCTURA R 57 valtorcitabine 57 INC# 57 Vidaza R 57 Restoraderm R 57 TAXUS Element Stent System 57 prescribed atypical antipsychotic 57 recombinant thrombin 57 low dose cytarabine 57 vemurafenib 57 pralatrexate injection 57 oropharyngeal candidiasis OPC 57 mifamurtide 57 BUPHENYL 57 Receives Orphan Drug Designation 57 Xanafide 57 oral deforolimus 57 injection USP 57 lymphoma CTCL 57 modified glutathione analog 57 IMA# 57 vapreotide acetate 57 ASP# 57 Neuromodulation System 57 Excellarate TM 57 Proxinium TM 57 Phenoptin 57 Carfilzomib 57 Tofacitinib 57 Saxagliptin 57 Onsolis 57 reduce serum phosphate 57 XIENCE V Stent System 57 Everolimus 57 metastatic dermatofibrosarcoma protuberans DFSP 57 CDK cyclin dependent 57 Urocidin 57 thrombolytic agent 57 Staphylococcus aureus Immune Globulin 57 LUMINATE 57 Mylan Receives Approval 57 Trobalt 56 tramiprosate ALZHEMED TM 56 diaper dermatitis complicated 56 NPS NPS Pharmaceuticals 56 Amigal 56 Advagraf 56 acetonide FA 56 NDA Submission 56 Receives Marketing Authorization 56 TRANSDUR Sufentanil 56 compound KOS 56 molecular imaging radiopharmaceutical 56 HP Acthar Gel repository 56 Efient 56 FIRAZYR 56 BRIM2 56 synthetic retinoid 56 Azedra 56 REG1 Anticoagulation System 56 recurrent metastatic ovarian cancer 56 SPRYCEL ® 56 Roche PEGASYS R 56 Perifosine 56 TRISENOX R arsenic trioxide 56 undergoing coronary angioplasty 56 Xerese 56 Orphan Drug 56 Application BLA 56 MPS VI 56 SUTENT 56 FavId 56 brand eszopiclone XOPENEX 56 cintredekin besudotox 56 VEGF Trap 56 SUTENT ® 56 subsidiaries visit http:/www.apricusbio.com 56 histone deacetylase HDAC inhibitor 56 topical antifungal 56 Phase IIb clinical trials 56 PRN FDA Approves 56 Increlex ® 56 sodium Injection 56 BEMA Fentanyl 56 DepoDur TM 56 Torisel 56 MYCAMINE 56 EGRIFTA ™ 56 catheter occlusion 56 Behcet uveitis 56 ketolide antibiotic 56 TRANSDUR Bupivacaine 56 voclosporin 56 systemic anaplastic large 56 Firazyr 56 Initiate Clinical Trial 56 orphan designation 56 budesonide foam 56 Fast Track designations 56 Clofarabine 56 Cloretazine 56 Tezampanel 56 LUCASSIN 56 PNP inhibitor 56 Solazed ™ 56 CIMZIA ™ 56 thalidomide Thalomid 56 cell lymphoma CTCL 56 CDP# 56 stage IIIB 56 Archexin 56 PEGylated Fab fragment 56 Leukine 56 HepaSphere 56 modafinil Tablets C 56 Actimmune ® 56 investigational oral inhibitor 56 Initiates Phase III 56 symptomatic BPH 56 humanized anti 56 drug ISA# 56 XIAPEX ® 56 Rescula 56 Abstral 56 trade name Normix 56 Xerclear ™ 56 ELADUR 56 Durezol TM 56 metastatic castrate resistant 56 Junovan TM 56 Aclasta 56 Brentuximab Vedotin SGN 56 talactoferrin 56 Cloretazine R VNP#M 56 refractory APL 56 refractory acute promyelocytic 56 PROVENGE ® 56 Zevtera 56 Regeneron Pharma 56 Aviptadil 56 Bicifadine 56 Zalbin 56 pralatrexate injection folate analogue 56 post herpetic neuralgia PHN 56 novel VDA molecule 56 Aceon 56 treat chronic sinusitis 56 PANVAC VF 56 vernakalant iv 56 Monovisc 56 POSIDUR TM 56 5 lipoxygenase inhibitor 56 placebo intravenously 56 Bronchitol 56 TACI Ig 56 granted Ortec 56 Phase IIIb 56 Ambrisentan 56 individualized cellular immunotherapy 56 Vandetanib 56 ® bortezomib 56 alvespimycin 56 BENLYSTA TM 56 Budesonide foam crofelemer 56 Acetavance TM 56 Tygacil 56 MEK Inhibitor 56 Twinject ® 56 Serostim ® 56 Pfizer Sutent 56 Intravenous CP 56 DAVANAT R 56 XL# XL# 56 Paraplatin ® 56 tramiprosate Alzhemed TM 56 P#X# antagonist 56 Phase III clinical 56 PrevOnco ™ 56 FACTIVE R gemifloxacin 56 idursulfase 56 Epratuzumab 56 PDE4 inhibitor 56 Soriatane 56 LymphoStat B belimumab 56 RoACTEMRA 56 SABER ™ 56 Nabi HB R 56 Prochymal TM 56 Ceflatonin 56 radiation sensitizer 56 Eltrombopag 56 Announces Tentative Approval 56 human C1 inhibitor 56 Cinryze TM 56 Soliris eculizumab 56 ADVEXIN 56 Leukine ® 56 Diamyd ® 56 IPLEX 56 Fodosine 56 Filgrastim 56 Invicorp R 56 CONBRIZA 56 PLK1 SNALP 56 Sycrest 56 Vidaza azacitidine 56 Aurexis R 56 neurogenic orthostatic hypotension 56 Evoltra ® 56 kidney urologic 56 alpha interferons 56 GEM #S 56 investigational mTOR inhibitor 56 secondary hyperparathyroidism 56 StaphVAX R 56 G#DT 56 IAP inhibitor 56 Alitretinoin 56 evaluating tivozanib 56 #-# rDNA origin 56 metastatic HRPC 56 Fx #A 56 Custirsen 56 Pralatrexate 56 post operative ileus 56 Hodgkin lymphoma HL 56 Omigard TM 56 novel synthetic PEGylated 56 documented candidiasis 56 L BLP# 56 gluteal injection 56 Mutual Recognition Procedure 56 ATG Fresenius S 56 SUMAVEL DosePro 56 treatment naive genotype 56 MEZAVANT R 56 oxaliplatin Eloxatin 55 Evicel 55 StemEx 55 castration resistant prostate cancer 55 ARCALYST ® 55 DC Bead 55 CHMP recommendation 55 AnGes 55 Firdapse 55 class mGluR5 inhibitor 55 Allovectin 7 r 55 BENLYSTA 55 ALN PCS 55 angiogenesis inhibitor 55 CINTREDEKIN BESUDOTOX 55 Granulocyte Colony Stimulating Factor 55 Generx TM 55 Arimoclomol 55 ZOMIG R 55 Solution XOPENEX HFA 55 thymalfasin 55 Medicinal Products EMEA 55 polymer platinate 55 treat lupus renal 55 candidates Augment ™ 55 ACTIQ ® 55 W2 Energy trades 55 Dupuytren Contracture 55 candidate ridaforolimus 55 Alocrest 55 Government Qualifying Therapeutic 55 Patient Enrollment 55 ALN HPN 55 OMNARIS Nasal Spray 55 Copegus ® 55 orally administered inhibitor 55 Sodium oxybate 55 OPAXIO 55 Pafuramidine 55 ofatumumab HuMax CD# 55 Telik logo TELINTRA 55 Phase IIb Trial 55 Entereg R 55 SNT MC# 55 LymphoStat B 55 Cimzia ® 55 C1 Inhibitor 55 CYCLOSET ® 55 diclofenac sodium 55 R Saizen R 55 MuGard TM 55 Augment TM 55 Etravirine 55 Pazopanib 55 intranasal formulation 55 Eligard R 55 AzaSite ® 55 Phase 2b clinical 55 BREAKYL 55 pentadentate logo R 55 Febuxostat 55 Amigal TM 55 novel emulsion formulation 55 PROPEL trial 55 Gleevec imatinib mesylate 55 liposomal formulation 55 miconazole Lauriad ® 55 Ovitrelle R Serostim 55 Kuvan TM sapropterin 55 HepeX B 55 candidate Zenvia 55 ocular formulation 55 HGS ETR1 mapatumumab 55 mild vasodilator 55 Zingo TM 55 bazedoxifene 55 Allos logo 55 Prednisporin 55 XL# XL# XL# XL# 55 Gabapentin GR 55 urethral bulking agent 55 Increlex 55 Phase III confirmatory 55 European Medicines Evaluation 55 tiapamil 55 Zerenex 55 BCR ABL inhibitor 55 ganetespib 55 lorvotuzumab mertansine 55 KIACTA ™ 55 containing active oxychlorine 55 REMOXY ® 55 Orathecin 55 Increlex TM 55 DDP# 55 Ocrelizumab 55 Maribavir 55 Tekamlo 55 Allos retains exclusive 55 ixabepilone 55 MEK inhibitor 55 Fast Track designation 55 dextofisopam 55 essential thrombocythemia ET 55 Prestara 55 LEVADEX TM 55 Through Glycoscience 55 Li Fraumeni Syndrome 55 Pegasys ® 55 Refractory Peripheral T 55 hyperimmune products 55 Meets Primary Endpoint 55 INCB# [003] 55 PROVENGE sipuleucel T 55 granted Orphan Drug 55 oritavancin semi 55 Clavis Pharma 55 ELACYT 55 acne impetigo 55 Evoltra TM 55 unresectable recurrent 55 AzaSite TM 55 sJIA 55 ZENPEP 55 ANCHOR trial 55 Channeling PMC procedure 55 IV FENTORA R 55 Relistor 55 Sylvie Gregoire President 55 novel histone deacetylase 55 synthetic lipoglycopeptide antibiotic 55 Bayer Nexavar 55 REPRONEX R menotropins 55 HCl PEPCID ® famotidine 55 Alseres Cethrin 55 Phase IIIb study 55 candidate AQ4N 55 investigational antiplatelet agent 55 Biologic License Application BLA 55 PREZISTA r 55 Cladribine Tablets 55 drug pipeline TAFA# 55 Factor VIIa 55 Pathway Inhibitor 55 HoFH 55 Nippon Kayaku 55 N acetylgalactosamine 6 55 Remicade infliximab